Introduction {#Sec1}
============

In mammalian cells, a considerable part of the proteome is subject to reversible acetylation of lysine residues (Choudhary et al. [@CR14]). Acetylation of the epsilon amino group of lysine side chains results in loss of the positive charge and affects several properties such as protein stability, protein--protein interaction and association of proteins with DNA. Moreover, acetylated lysine residues are recognized and bound by bromodomain-containing factors. Thus reversible lysine acetylation has an impact on a diverse range of important biological processes in the cell (Yang and Seto [@CR119]). The best-studied substrates for this post-translational modification are the basic histone proteins. Acetylation of the N-terminal histone tails increases the accessibility of DNA for the RNA polymerase machinery and sets the stage for transcription. The dynamic process of histone acetylation is controlled by two antagonistic enzyme families, the histone acetyltransferases (HATs) and the histone deacetylases (HDACs) (reviewed by Brunmeir et al. [@CR10]). Transcriptionally permissive chromatin is usually associated with histone acetylation, conducted by the HATs, whereas HDACs remove the acetyl groups from the histone tail and are generally considered as transcriptional co-repressors (Grunstein [@CR35]). While histones were the first proteins found to be deacetylated by HDACs, a plethora of non-histone substrates has been identified during the last decade (Patel et al. [@CR79]; Wolffe [@CR109]). Therefore HDACs are also called lysine (K) deacetylases (KDACs). However, to better link the discussed topics to published data we will refer to the individual enzymes as HDACs. Based on the homologies to yeast enzymes, 18 KDACs have been identified in mammals. The KDAC family encompasses the following deacetylases: Rpd3-like class I: HDAC1, 2, 3, 8; Hda1-like class II: HDAC4, 5, 6, 7, 9 and 10; class IV: HDAC11 and the mechanistically unrelated Sir2-like class II: sirtuins SIRT1-7 (Witt et al. [@CR108]).

The first protein shown to have histone deacetylase activity was HDAC1, a mammalian homolog of the yeast pleiotropic transcriptional regulator Rpd3 (reduced potassium dependency 3) (Taunton et al. [@CR93]). Yeast Rpd3 was initially identified in genetic screens as regulatory factor "required to achieve maximum positive and negative transcriptional states" (Stillman et al. [@CR89]; Vidal and Gaber [@CR100]). Three additional Rpd3-like deacetylases ---HDAC2, HDAC3 and HDAC8 --- have been subsequently found in mammalian cells and constitute together with HDAC1 the class I KDAC subfamily (Dangond et al. [@CR19]; Emiliani et al. [@CR26]; Hu et al. [@CR47]; Yang et al. [@CR115], [@CR117]).

Structure and localization of class I KDACs {#Sec2}
===========================================

The structures of the genes for *Hdac1* and *Hdac2* are nearly identical indicating that the two genes most probably arose from gene duplication of a common ancestor (Khier et al. [@CR54]; Zeng et al. [@CR123]). In contrast, the *Hdac3* and *Hdac8* genes have different exon/intron structures (Mahlknecht et al. [@CR67]). Accordingly, HDAC1 and HDAC2 proteins are the most related among the class I HDACs, exhibiting 86 % of amino acid sequence identity in mice and men, suggesting that they have undergone only little functional divergence from each other (Gregoretti et al. [@CR33]). The catalytic domain is positioned at the N-terminus of HDAC1 and HDAC2 forming the major part of the protein. The N-terminus of HDAC1 also harbors the HDAC association domain (HAD) important for homo-dimerization, whereas the C-terminal part contains a nuclear localization domain (NLS) (Taplick et al. [@CR92]). A coiled-coil domain which presumably serves as protein--protein interaction domain is present within the C-terminus of HDAC2 (Gregoretti et al. [@CR33]). Both enzymes are usually localized to the nucleus. As an exception HDAC1 was reported to show cytosolic localization in the axons of human and murine neurons under pathological conditions (Kim et al. [@CR56]).

HDAC3 shares 63/62 % identical amino acids with HDAC1/HDAC2 and has 43 % sequence identity to HDAC8. In addition to the NLS on the C terminus, HDAC3 has a nuclear export signal (NES), consistent with its ability to localize both to the nucleus as well as to the cytoplasm (Takami and Nakayama [@CR91]; Yang et al. [@CR116]). HDAC3 forms homo-oligomers but can also associate with class II KDACs (Fischle et al. [@CR29], [@CR30]; Yang et al. [@CR116]). HDAC8, the most recently identified class I KDAC comprises the NLS in the center of the catalytic domain and locates to the nucleus upon overexpression in human cells (Hu et al. [@CR47]; Van den Wyngaert et al. [@CR96]). Another report has described a cytosolic localization of HDAC8 in smooth muscle cells (Waltregny et al. [@CR101]).

Complexes and modifications of class I KDACs {#Sec3}
============================================

HDAC1 and HDAC2 can homo- and hetero-dimerize (Hassig et al. [@CR42]; Taplick et al. [@CR92]), while HDAC3 forms homo-oligomers (Gregoretti et al. [@CR33]; Yang et al. [@CR116]) and HDAC8 is found as a dimer (Vannini et al. [@CR97], [@CR98]). Recombinant HDAC8 catalyzes the deacetylation of specific substrates in the absence of additional proteins (reviewed by Wolfson et al. [@CR110]). In contrast, the other three class I KDACs are enzymatically inactive after purification (Gregoretti et al. [@CR33]; Sengupta and Seto [@CR88]; Yang and Seto [@CR118]). The catalytic activity of HDAC1 and HDAC2 is largely dependent on its incorporation into multiprotein complexes (Alland et al. [@CR1]; Zhang et al. [@CR125]). These complexes provide proteins important for the deacetylase activity, DNA- and chromatin-binding as well as substrate specificity (Grozinger and Schreiber [@CR34]). The predominant HDAC1/HDAC2 complexes in mammalian cells are the Sin3, NuRD and CoREST complexes (Alland et al. [@CR2]; Ballas et al. [@CR3]; Heinzel et al. [@CR45]; Laherty et al. [@CR59]; Zhang et al. [@CR124]). The NODE complex is a specialized HDAC1/HDAC2 complex present in embryonic stem cells and the SHIP complex has a specific function during spermatogenesis (Choi et al. [@CR13]; Liang et al. [@CR63]). MiDAC is a novel mitosis-specific deacetylase complex recently identified in a chemoproteomics approach (Bantscheff et al. [@CR4]). Interestingly, in cardiomyocytes HDAC1 was shown to associate with the class II KDAC HDAC5 during the regulation of sodium/calcium exchanger (Chandrasekaran et al. [@CR11]).

HDAC3 is the catalytic component of the N-CoR/SMRT complex. The enzyme is re-folded by the TCP-1 ring complex before connecting to the SMRT and the N-CoR co-repressors which harbor a deacetylase-activating domain for the stimulation of the enzymatic activity of the HDAC3 protein (Guenther et al. [@CR37], [@CR38]). In addition, HDAC3 can associate with the class II KDACs HDAC4, HDAC5 and HDAC7 and the enzymatic activity of HDAC7 was shown to be dependent on the interaction with HDAC3 (Fischle et al. [@CR29]; Yang et al. [@CR116]). An overview of the different co-repressor complexes of class I KDACs is given in Fig. [1](#Fig1){ref-type="fig"}. Interestingly, it was shown recently that inositol-tetraphosphate (IP4) positively affects class I KDAC co-repressor complex formation and activity (Millard et al. [@CR70]; Watson et al. [@CR105]). Based on these findings, the authors suggested that IP4 acts as intermolecular glue between deacetylases and co-repressor proteins thereby enhancing the deacetylase activity of HDAC3--SMRT and HDAC1--MTA1 complexes.Fig. 1Class I KDACs are deposited in distinct multi-subunit complexes or act on their own. HDAC1/HDAC2 homo- and hetero-dimers are found in the three canonical co-repressor complexes, CoREST, Sin3 and NuRD, and additionally in the ES cell-specific NODE and the mitotic MiDAC complex (*left panel*). HDAC3 assembles as dimer with the NCoR/SMRT complex (*middle panel*), while HDAC8 is not dependent on incorporation into complexes for its enzymatic activity (*right panel*)

Besides their subcellular localization and incorporation into multi-subunit complexes, class I KDACs can also be regulated by post-translational modifications including phosphorylation, acetylation, ubiquitination, SUMOylation, nitrosylation and carbonylation (reviewed by Segre and Chiocca [@CR86]; Wolfson et al. [@CR110]). These modifications modulate their catalytic activity, localization and complex assembly.

HDAC1, HDAC2 and HDAC3 are subjected to phosphorylation by the protein kinase CK2 which can enhance the enzymatic activity as well as the interaction with multi-subunit complex partners (Pflum et al. [@CR80]; Tsai and Seto [@CR95]). Interestingly, CK2-mediated phosphorylation of HDAC1/HDAC2 during mitosis leads to dissociation from each other and thereby to the absence of mitotic HDAC1/2 hetero-dimers (Khan et al. [@CR53]). HDAC8 is phosphorylated in vitro and in vivo by protein kinase A (PKA), which negatively impacts on the catalytic activity (Lee et al. [@CR61]).

Likewise, KDACs are also subject to reversible acetylation. HDAC1 can be acetylated by CBP/p300 resulting in decreased enzymatic activity (Qiu et al. [@CR81]). Deacetylation and concomitant activation of HDAC1 by SIRT1 has been shown to be important for the maintenance of genomic stability in neurons (Dobbin et al. [@CR22]). Despite the fact that five of the six acetylatable lysines are conserved in HDAC2, it cannot be acetylated in vitro due to the lack of lysine 432, which seems to be the crucial residue for acetylation. Accordingly, C-terminal tail-swapping experiments between HDAC1 and HDAC2 showed full HDAC2 acetylation due to the substituted C-terminal region originating from HDAC1 (Luo et al. [@CR64]).

Class I KDACs are also subjected to ubiquitination, which targets them for proteasomal degradation, and sumoylation. For instance, HDAC1 can be sumoylated (Colombo et al. [@CR17]; David et al. [@CR20]), but only SUMO1 and not SUMO2 conjugation to HDAC1 promotes its ubiquitination and degradation (Citro et al. [@CR15]). Thus, specific SUMO paralog conjugation affects HDAC1 protein turnover in mammalian cells.

Cigarette smoke extract-induced tyrosine nitration of HDAC1, HDAC2 and HDAC3 and down-regulation of their protein levels was observed in macrophages (Yang et al. [@CR114]). In neurons cysteine (*S*)-nitrosylation of HDAC2 was reported to induce chromatin remodeling, triggering the release of HDAC2 from neurotrophin-dependent promoters and thereby stimulating transcription (Nott et al. [@CR78]). In addition, HDAC8 can be *S*-nitrosylated in vitro, which reversibly inhibits its enzymatic activity (Feng et al. [@CR28]). However, this modification of HDAC8 could not be detected under physiological conditions in vivo.

Moreover, class I deacetylases with the exception of HDAC8 can be carbonylated, which negatively affects their deacetylase activity and hence their transcriptional repressor activity (Doyle and Fitzpatrick [@CR25]).

Non-histone substrates {#Sec4}
======================

Genealogical studies indicate that the deacetylation of non-histone substrates was their primary function, since in evolution bacterial KDACs arose ahead of the histone proteins (Gregoretti et al. [@CR33]). Analysis of the acetylome by high-resolution mass spectrometry has revealed the presence of 3,600 lysine acetylation sites on 1,750 human proteins (Choudhary et al. [@CR14]). A subset of these acetylation marks was increased by treatment with the class I KDAC inhibitor MS-275 indicating that class I enzymes recognize many non-histone proteins as substrates. Such non-histone targets comprise transcription factors, proteins involved in chromatin modifications, DNA repair, signal transduction, nuclear import as well as chaperone proteins, structural proteins, tumor suppressors and steroid receptors. Interestingly, several components of KAT and KDAC complexes including HDAC1, HDAC2, and several other proteins of the Sin3 and the NuRD complexes are targets for lysine acetylation (Choudhary et al. [@CR14]). Furthermore, HDAC3 was shown to deacetylate not only the transcription factor MEF2 but also the corresponding acetyltransferases PCAF and p300/CBP (Gregoire et al. [@CR32]). Given that class I KDACs can deacetylate histones, KDAC-recruiting factors, components of the co-repressor complexes and even KATs, it is challenging to dissect the individual contributions of histone and non-histone substrates to the biological function of specific KDACs (see below).

Role of class I KDACs in transcription {#Sec5}
======================================

According to the textbook view histone acetylation is linked with transcriptional activation, while histone deacetylation is associated with gene repression. Co-repressor complexes are usually recruited by transcription factors, however non-coding RNAs might also play a role in the association of KDAC complexes with chromatin (Yang and Seto [@CR119]). The association of the KDAC complexes with chromatin is further modulated by the affinity of histone interaction domains of specific components of the co-repressor complexes. All major HDAC1/HDAC2 complexes have components with reader domains such as SANT, chromo- and tudor domains, PhD fingers or WD40 repeats, which interact with histones in a modification-dependent manner (Kelly and Cowley [@CR52]). In vitro experiments have shown that HDAC3-containing N-CoR/SMRT complexes bind preferentially to hypoacetylated histones (Vermeulen et al. [@CR99]; Yoon et al. [@CR121]; Yu et al. [@CR122]). A similar feed-forward mechanism based on the preferential association with hypoacetylated histone H3 was also proposed for the HDAC1/HDAC2 co-repressor complex Sin3 (Vermeulen et al. [@CR99]). On the other hand, the presence of active histone marks such as H3K4me3 and H3S10ph reduced the affinity of HDAC1/HDAC2 complexes for the N-terminus of histone H3 in in vitro assays (He et al. [@CR43]; Nishioka et al. [@CR76]). Thus, both the DNA sequence and local chromatin modification patterns control the recruitment of class I KDAC complexes to specific genomic regions.

However, this conventional view of class I KDACs as silencing factors has been challenged during the past years by several studies showing that histone deacetylase activity is important for the activation of certain genes and that HDAC1 and HDAC2 preferentially associate with active genes (Clayton et al. [@CR16]; Kidder and Palmer [@CR55]; Wang et al. [@CR102], [@CR104]; Zupkovitz et al. [@CR129]). In a genome-wide ChIP-seq analysis in human CD4+ cells a positive correlation between HDAC1/HDAC2 binding, histone acetylation and transcription was discovered (Wang et al. [@CR104]). In this cell system high levels of class I KDACs and KATs associated with transcriptionally active genes. In contrast, silent genes lacked the presence of KATs or KDACs and were not associated with hyperacetylated histones upon KDAC inhibition. According to the model proposed by the authors KDACs (and KATs) are recruited to active genes to dynamically change histone acetylation patterns and to reset the chromatin structure for the next rounds of transcription (Wang et al. [@CR104]).

The situation is further complicated by the fact that class I KDACs not only remove acetyl groups from histones tails but can also deacetylate transcription factors and other chromatin-associated proteins. Indeed, several HDAC1/HDAC2 recruiting transcription factors and components of HDAC1/HDAC2 co-repressor complexes have been also shown to be substrates for acetylation (Choudhary et al. [@CR14]; Patel et al. [@CR79]). In addition, as mentioned above KATs and KDACs are also subject to acetylation (Dobbin et al. [@CR22]; Luo et al. [@CR64]; Qiu et al. [@CR81]). Thus, chromatin-associated class I KDACs can affect gene transcription on several levels (Fig. [2](#Fig2){ref-type="fig"}). Recruitment of KDACs as catalytic components of multiprotein complexes results in dynamic changes of histone acetylation patterns. In addition, several of the recruiting transcription factors are themselves targets for reversible acetylation and their protein stability or function can be regulated by class I KDACs. Furthermore, acetylation of specific components of the co-repressor complexes might modulate the activity and stability of these multiprotein complexes. Finally, the acetylation cross-talk between KDACs and KATs by mutual modification can result in modulation of the local activity of the respective chromatin-associated enzymes.Fig. 2Intricate network of acetylated substrates involved in transcription. In addition to the dynamic and reversible acetylation/deacetylation of histone tails, transcription factors (*TF*), KATs and KDACs themselves as well as structural (*scaffold*) and regulatory (labeled as *R*) components of co-repressor complexes can be reversibly acetylated, potentially leading to changes in local transcriptional activity

Non-transcriptional functions of class I KDACs {#Sec6}
==============================================

In addition to their well-studied role in transcription, other important functions of class I KDACs have emerged during the past years (summarized in Fig. [3](#Fig3){ref-type="fig"}).Fig. 3The class I subfamily of lysine deacetylases is involved in several cellular processes. Besides transcription, HDAC1, HDAC2, HDAC3 and/or HDAC8 play crucial roles during splicing, DNA repair, replication, mitosis and meiosis

Splicing {#Sec7}
--------

For instance, KDACs have been shown to affect alternative splicing (Hnilicova et al. [@CR46]; Nogues et al. [@CR77]). Analysis of genome-wide nucleosome positioning data had previously revealed increased nucleosomal occupancy at exons (Schwartz et al. [@CR85]). Hu RNA-binding proteins can associate with HDAC2 thereby inhibiting its deacetylation activity and inducing local histone hyperacetylation at the chromatin of alternatively spliced genes (Zhou et al. [@CR126]). KDAC inhibitor treatment of HeLa cells led to altered splicing of nearly 700 human genes. Treatment with sodium butyrate induced histone H4 acetylation and increased RNA Pol II processivity and exon skipping at the fibronectin gene (Hnilicova et al. [@CR46]). This effect could be recapitulated by siRNA-mediated knock-down of HDAC1 but not HDAC2. The alternative splicing defect in HDAC1-depleted cells could be rescued by the expression of the wildtype HDAC1 protein, but not by a catalytically inactive variant, suggesting a specific requirement for HDAC1-associated deacetylase activity for the regulation of alternative splicing. Notably, about 50 % of the proteins building the spliceosome are acetylated, however the relevance of this potential link between KDAC function and splicing remains to be established (Choudhary et al. [@CR14]).

Replication and DNA repair {#Sec8}
--------------------------

KDAC inhibition in cancer cells has been shown to slow down replication and to induce DNA damage suggesting an important function of KDACs during DNA synthesis (Conti et al. [@CR18]). Indeed, class I KDACs have been identified as crucial components of the replication and DNA repair machinery.

The simultaneous deletion of *Hdac1* and *Hdac2* resulted in G1 arrest and severely reduced BrdU incorporation indicating a block in S-phase transition (Wilting et al. [@CR106]; Yamaguchi et al. [@CR113]). Ablation of HDAC1 and HDAC2 was recently reported to cause increased acetylation of H4K16 on nascent chromatin, decreased replication fork velocity and activation of the replication stress response (Bhaskara et al. [@CR7]). HDAC1 and HDAC2 were found to be located at the replication fork and seem to be required for removing specific histone acetylation marks that might otherwise interfere with the activity of ISWI-family chromatin remodelers (Bhaskara et al. [@CR7]). Induction of DNA double-strand breaks in human osteosarcoma cells in the absence of HDAC1/HDAC2 resulted in increased H3K56 acetylation, a modification linked to DNA damage (Miller et al. [@CR71]). In this study, loss of HDAC1 and HDAC2 was found to affect the persistence of NHEJ (non-homologous end-joining) factors at DNA double-strand breaks and to result in hypersensitivity to DNA-damaging agents suggesting a function of these enzymes in the DNA-damage response. In accordance, simultaneous ablation of HDAC1 and HDAC2 in the developing mouse brain led to DNA damage and enhanced H3K56 acetylation (Hagelkruys et al. [@CR41]). Interestingly, HDAC1 was recently found to collaborate with SIRT1 in the maintenance of genomic stability in neurons (Dobbin et al. [@CR22]).

HDAC3-deficient fibroblasts display impaired S phase progression and inefficient DNA repair leading to DNA damage and apoptosis (Bhaskara et al. [@CR6]). Furthermore, ablation of HDAC3 in hematopoietic progenitor cells revealed a requirement of this deacetylase for the passage through S phase (Summers et al. [@CR90]). HDAC3-deficient cells show elevated levels of nucleosome deposition marks such as H4K5ac and H4K12ac accompanied by a loss of heterochromatin, an increase in DNA double-strand breaks and reduced proliferation (Bhaskara et al. [@CR6], [@CR8]). In summary, HDAC1/HDAC2 and HDAC3 have distinct non-redundant functions during replication and DNA repair.

Mitosis/meiosis {#Sec9}
---------------

Overexpression of HDAC1 in mouse fibroblasts resulted in a partial G2/M block and aberrant nuclear morphology, whereas knock-down of HDAC1 in human tumor cells also led to impaired mitosis suggesting a requirement for balanced acetylation/deacetylation during mitosis (Bartl et al. [@CR5]; Senese et al. [@CR87]). Along this line, HDAC1/HDAC2-deficient transformed mouse fibroblasts display nuclear bridging, nuclear fragmentation, and mitotic catastrophe (Haberland et al. [@CR39]). Recently, the multi-zinc-finger protein TRPS1 encoded by the gene mutated in human \"Tricho-Rhino-Phalangeal syndrome\" was shown to associate with HDAC1 and HDAC4 (Wuelling et al. [@CR111]). Loss of TRPS1 in murine chondrocytes resulted in increased H3 acetylation and impaired chromatin condensation during mitosis. However the underlying molecular mechanisms for the essential function of HDAC1/HDAC2 during mitosis remain to be identified. Remarkably, loss of HDAC2 causes increased H4K16 acetylation and defective chromosome condensation and segregation during oogenesis providing evidence for a critical role of HDAC2 during meiosis (Ma and Schultz [@CR66]).

Several reports describe an essential role for HDAC3 during mitosis. Li et al. have shown that HDAC3 is targeted together with the A-Kinase-Anchoring proteins AKAP95 and HA95 to mitotic chromosomes to generate a hypoacetylated H3 tail as preferred template for Aurora B kinase (Li et al. [@CR62]). Phosphorylation of H3S10 by Aurora B led to the dissociation of HP1 from the neighboring methylated H3K9 residue and is a crucial step during mitosis. Thus, the non-transcriptional function of HDAC3 during mitosis is a prerequisite for the H3S10 kinase activity of Aurora B. Furthermore, HDAC3 was shown to be required for deacetylation of H3K4 at the centromere and sister chromatin cohesion (Eot-Houllier et al. [@CR27]). Finally, a complex formed by HDAC3, N-CoR, TBL1 and TBLR1 is localized at the mitotic spindle and its activity is pivotal for kinetochore-microtubule attachment (Ishii et al. [@CR48]).

Recently, it was reported that HDAC8 deacetylates cohesin and that the enzyme is implicated in Cornelia de Lange Syndrome (CdLS) (Deardorff et al. [@CR21]). Cohesins form a ring structure encircling sister chromatids and have important functions for sister chromatid cohesion as well as for transcription control. Loss of HDAC8 resulted in elevated acetylation of one of the cohesion subunits SMC3 and impaired dissolution of the cohesin complex from chromatin during mitosis. Importantly, Deardorff et al. ([@CR21]) identified loss-of-function mutations in the *Hdac8* gene in six CdLS probands.

Knock-out studies --- full deletions {#Sec10}
====================================

A lot of effort has been put into the investigation of the specific functions of class I KDACs in development, proliferation and differentiation by loss-of-function studies in mice. Germline deletion of *Hdac1* in mice results in embryonic lethality before embryonic day E10.5. These mice show severe developmental and proliferation defects as well as growth retardation (Lagger et al. [@CR57]; Montgomery et al. [@CR72]; Yamaguchi et al. [@CR113]). HDAC1 represses the cyclin-dependent kinase inhibitor p21^WAF1/CIP1^ and thus positively regulates proliferation. Indeed p21^WAF1/CIP1^ is up-regulated in HDAC1 knock-out mice and HDAC1-deficient mouse embryonic stem (ES) cells (Lagger et al. [@CR57]). The proliferation defect in ES cells but not the lethal phenotype of HDAC1 knock-out mice could be rescued by the deletion of *p21*^*WAF1*/*CAF1*^ (Zupkovitz et al. [@CR128]). In mice and ES cells deficient for HDAC1, the HDAC2 protein is up-regulated but is not fully capable to compensate for the loss of HDAC1 (Lagger et al. [@CR57]; Zupkovitz et al. [@CR129], [@CR128]). Depending on the knock-out strategy, deletion of *Hdac2* in mice results in perinatal lethality (Montgomery et al. [@CR72]), partial perinatal lethality (Guan et al. [@CR36]) or partial lethality within the first months (Trivedi et al. [@CR94]; Zimmermann et al. [@CR127]). These knock-out studies attribute specific functions to the highly homologous enzymes HDAC1 and HDAC2. Knock-out of HDAC3 also results in embryonic lethality before embryonic day E9.5 due to gastrulation defects (Bhaskara et al. [@CR6]; Montgomery et al. [@CR74]). Global loss of HDAC8 in mice results in skull instability and perinatal lethality (Haberland et al. [@CR40]).

Knock-out studies --- conditional deletions {#Sec11}
===========================================

Since global germline ablation of class I KDACs caused early lethality, conditional cre recombinase-mediated deletions were instrumental in revealing the functions of these deacetylases in specific tissues. Loss of either HDAC1 or HDAC2 in cell types including ES cells, fibroblasts, B cells, thymocytes, keratinocytes, cardiomyocytes, neurons, Schwann cells and various cell lines caused no or only mild effects (Chen et al. [@CR12]; Dovey et al. [@CR24], [@CR23]; Grausenburger et al. [@CR31]; Guan et al. [@CR36]; Jawerka et al. [@CR50]; Jurkin et al. [@CR51]; Lagger et al. [@CR57]; LeBoeuf et al. [@CR60]; Montgomery et al. [@CR72]; Winter et al. [@CR107]; Yamaguchi et al. [@CR113]). In most of these cell types, deletion of *Hdac1* led to an increased protein level of HDAC2 and vice versa, most probably compensating for the loss of the respective paralog and thereby masking the knock-out phenotype.

Mild phenotypes were observed for instance upon knock-out of HDAC1 in T cells and ES cells as well as loss of HDAC2 in oocytes and the nervous system. In T cells absence of HDAC1 provoked increased airway inflammation and elevated Th2 cytokine production in an in vivo asthma mouse model, indicating that HDAC1 modulates the inflammatory response (Grausenburger et al. [@CR31]). Similarly deletion of *Hdac1* in ES cells resulted in enhanced differentiation of embryoid bodies, highlighting a crucial role of HDAC1 in cell fate determination during differentiation (Dovey et al. [@CR24]). Conversely, loss of HDAC2 in oocytes led to sub-fertile mice due to H4K16 hyperacetylation and affected chromosome segregation (Ma et al. [@CR65]; Ma and Schultz [@CR66]). Deficiency of HDAC2 in adult neural stem cells caused defects in adult neurogenesis (Jawerka et al. [@CR50]), while another report found enhanced synapse number and memory formation upon loss of HDAC2 (Guan et al. [@CR36]). Together these data suggest requirement of HDAC2 during adult neuronal progenitor differentiation and implication of HDAC2 in synaptic plasticity after neuronal maturation. Deletion of either *Hdac1* or *Hdac2* in the murine epidermis does not evoke an obvious phenotype (LeBoeuf et al. [@CR60]; Winter et al. [@CR107]). Importantly, the ablation of HDAC1, but not of HDAC2 in a genetic skin tumor model results in accelerated tumor development, implicating a tumor suppressor function for HDAC1 in the epidermis (Winter et al. [@CR107]). A potential tumor suppressor function for HDAC1 was also discovered in T cells and B cells (Dovey et al. [@CR23]; Heideman et al. [@CR44]; Santoro et al. [@CR84]). In accordance loss of HDAC1 in teratomas resulted in decreased differentiation and enhanced malignancy due to deregulated SNAIL1 signaling (Lagger et al. [@CR58]).

In contrast to individual conditional deletions of *Hdac1* or *Hdac2*, which mostly do not evoke strong phenotypes, the combined conditional loss of HDAC1 and HDAC2 results in dramatic defects in proliferation, differentiation, survival and transcriptional regulation in most cell types and tissues. Both in fibroblasts and B cells, simultaneous loss of HDAC1 and HDAC2 led to a strong cell cycle block in G1 followed by cell death (Yamaguchi et al. [@CR113]). Similarly, dual ablation of HDAC1 and HDAC2 in neuronal precursor cells resulted in failure to differentiate into mature neurons and apoptosis (Montgomery et al. [@CR73]). Collective loss of HDAC1 and HDAC2 led to impaired development of different cell types due to transcriptional deregulation of important signaling pathways. Combined loss of HDAC1 and HDAC2 was linked to deregulation of the p53/p63 pathway and apoptosis in the epidermis (LeBoeuf et al. [@CR60]), de-repression of Bmp4 and Rb1 in the lung (Wang et al. [@CR103]), inappropriate activation of Wnt/β-catenin signaling in oligodendrocytes (Ye et al. [@CR120]) and impaired T-cell receptor signaling and apoptosis in thymocytes (Dovey et al. [@CR23]; Heideman et al. [@CR44]). Likewise, dual HDAC1/2 ablation resulted in apoptotic megakaryocytes, anemia and thrombocytopenia in the hematopoietic system (Wilting et al. [@CR106]; Yamaguchi et al. [@CR113]), hyperacetylation of TRP53 followed by apoptosis in oocytes (Ma et al. [@CR65]), mitotic failure in proliferating hepatocytes (Xia et al. [@CR112]) or decreased autophagy in skeletal muscles (Moresi et al. [@CR75]). Upon simultaneous HDAC1/2 deletion in Schwann cells, myelin deficiency and massive cell loss were observed and attributed at least in part to hyperacetylation of NF-κB (Chen et al. [@CR12]; Jacob et al. [@CR49]).

Notably, combined loss of HDAC1 and HDAC2 induces DNA damage or chromosomal abnormalities finally resulting in apoptosis in a variety of cell types and organs including T cells (Dovey et al. [@CR23]; Heideman et al. [@CR44]), B cells (Yamaguchi et al. [@CR113]), brain (Hagelkruys et al. [@CR41]) and transformed fibroblasts (Haberland et al. [@CR39]). Accordingly, proliferating cells cannot tolerate simultaneous lack of HDAC1 and HDAC2, implying that drugs inhibiting both enzymes are promising anti-cancer drugs.

Importantly, deletion of three of the four *Hdac1*/*Hdac2* alleles allowed dissecting the individual functions of HDAC1 and HDAC2 in different cell types and tissues. Haploinsufficency of *Hdac1* in the absence of HDAC2 and thereby a more important function of HDAC2 was identified in oocytes, where the enzyme regulates chromosome segregation and kinetochore function (Ma and Schultz [@CR66]). A similar situation was observed in the developing nervous system, where HDAC2 represses protein kinase C delta and thereby inhibits premature differentiation (Hagelkruys et al. [@CR41]).

Interestingly, only the opposite allelic combination, a single *Hdac2* allele in the absence of HDAC1, resulted in phenotypes when deleted in keratinocytes and thymocytes. Haploinsufficiency of *Hdac2* in the absence of HDAC1 in the epidermis led to strongly impaired epidermal development due to mobilization of epidermal stem cells, hyperproliferation and increased differentiation (Winter et al. [@CR107]). Elevated proliferation in the epidermis was accompanied by post-transcriptional up-regulation of the c-Myc protein, highlighting once more transcription-dependent and independent effects of class I KDACs.

In T cells, a comparable positive effect on cell proliferation by a single *Hdac2* allele in the absence of HDAC1 was shown to favor tumor formation (Dovey et al. [@CR23]; Heideman et al. [@CR44]). Furthermore, one allele of *Hdac1* in the absence of HDAC2 was sufficient to restore proper B cell development, while the vice versa situation (one allele of *Hdac2* in the absence of HDAC1) could not rescue the cell cycle block and apoptosis (Reichert et al. [@CR83]). Interestingly, the different *Hdac1*/*2* allele-specific effects are in some cases dependent on the remaining level of HDAC activity (Dovey et al. [@CR23]; Heideman et al. [@CR44]; Matthias [@CR68]). In contrast, in the developing brain the highly divergent phenotypes of *Hdac1*+/− *Hdac2*−/− and *Hdac1*−/− *Hdac2*+/− mice could not be explained by differential reduction of HDAC activity, but rather by specific effects of HDAC1 and HDAC2 on co-repressor function. It is tempting to speculate that HDAC1 and HDAC2 have different cell type-specific affinities for co-repressor complexes that are further modulated by various post-translational modifications such as phosphorylation, acetylation and sumoylation. Taken together this reveals overlapping, but specific functions of HDAC1 and HDAC2 in different tissues during mouse development.

Since HDAC1 and HDAC2 are paralogs and show redundancy in many cell types, their individual deletion did not evoke severe phenotypes. On the contrary, loss of HDAC3 and HDAC8 could not be compensated by another deacetylase and caused developmental defects and often lethality. Liver-specific ablation of HDAC3 led to hepatocellular carcinomas due to impaired response to DNA damage and genomic instability in hepatocytes (Bhaskara et al. [@CR8]). Conditional deletion of *Hdac3* in osteo-chondroprogenitor cells decreased bone length and caused severe osteopenia due to suppression of the Akt/mTOR pathway (Bradley et al. [@CR9]; Razidlo et al. [@CR82]). Cardiac-specific deletion of *Hdac3* resulted in cardiac hypertrophy and aberrant expression of cardiac metabolism genes, highlighting the role of HDAC3 in the maintenance of cardiac function and in the regulation of cardiac energy metabolism (Montgomery et al. [@CR74]). Besides the crucial role of HDAC3 in genomic stability in different cell types, maintenance of cardiac metabolism and formation/maturation of bone, HDAC3 was found to negatively regulate memory formation (McQuown et al. [@CR69]).

Conditional deletion of *Hdac8* in neural crest cells phenocopied the global deletion, showing skull instability and perinatal lethality (Haberland et al. [@CR40]).

Taken together, these findings demonstrate that class I KDACs possess highly specific in vivo functions.

Summary and outlook {#Sec12}
===================

By deacetylating histones and a growing number of non-histone substrates, class I KDACs play fundamental roles in transcription. Importantly, lysine deacetylases do not only control dynamic changes in histone acetylation, but also remove acetyl groups from transcription factors, co-repressor complex subunits and KATs and KDACs themselves thereby potentially modulating their stability and function.

During the past years, several non-transcriptional roles of the class I subfamily have emerged and have implicated HDAC1, HDAC2, HDAC3 and HDAC8 in biological processes including replication, DNA repair, splicing and mitosis/meiosis.

Originating from gene duplication the two paralogs HDAC1 and HDAC2 have partially overlapping, but also specific functions in different cell types, while the other class I subfamily members HDAC3 and HDAC8 are more distinct and thereby have non-redundant roles. The redundant functions of HDAC1 and HDAC2 are visible upon simultaneous deletion of both enzymes, which is incompatible with normal cellular proliferation and development. Since the individual contributions of HDAC1 and HDAC2 are partially masked by the up-regulated paralog in single knock-outs, an important step to reveal isoform-specific functions was the deletion of three of the four *Hdac1*/*2* alleles in different cellular systems.

Due to the contribution of class I KDACs to cancer and neurological disorders, KDAC inhibitors are promising drugs in several diseases. Despite the growing number of KDAC knock-out mice, identification of non-histone substrates and increasing knowledge about KDACs in pathological conditions, the individual contribution of particular KDAC members to normal development and disease is not completely understood. The key to fully elucidate the effects of KDAC knock-outs or KDAC inhibitor treatment is to complete the picture by comparing the cell type-specific expression patterns and local chromatin association of KDACs with the ones of the antagonistic KATs.
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